On February 02, 2016 16:00 (IST)
UPL, Sun TV Network, MRPL, Jidal Steel, NALCO, Torrent Pharma, JSW Steel and Glenmark were among the losers from the mid-cap space, down 3-4.6 per cent each.
On January 10, 2016 13:52 (IST)
Overall weakness in the equity market dragged down the combined market valuation of nine of the top ten most valued Indian companies by a whopping Rs 78,511.56 crore for the week ended January 8.
On December 29, 2015 15:53 (IST)
Some amount of buying was visible in realty, pharma, media and infrastructure shares while mild selling pressure was seen in select metal, IT and banking stocks.
On December 28, 2015 14:28 (IST)
Sarvendra Srivastava, CMT-head technical research at Phisense.com, says the Nifty has managed to close above the important 7,850 levels in the holiday-shortened week (December 21-24) despite weak volumes.
On December 22, 2015 17:56 (IST)
Shares of Sun Pharma rebounded on Tuesday after slumping 4.5 per cent on Monday. Shares of India's biggest pharma company gained as much as 2 per cent today on value-buying at lower levels.
On December 21, 2015 12:36 (IST)
Shares in India's largest drugmaker, Sun Pharmaceutical Industries Ltd, skidded more than 7 percent on Monday after U.S. regulators warned of standards violations at a key plant in the latest blow to India's generic drug industry.
On December 21, 2015 16:02 (IST)
The Sensex rose 217 points to close at 25,736 and the 50-share Nifty advanced 72 points to settle at 7,834 on the back of gains in banking, metal and IT shares.
On December 21, 2015 15:40 (IST)
The US Food and Drug Administration's (US FDA) warning letter to Sun Pharma indicates the agency is dissatisfied with the remedial measures the company has implemented since last September, when the FDA first notified the company of its concerns after an inspection.
On December 15, 2015 19:24 (IST)
However, the company did not disclose the financial details of the transaction. Sun Pharma said impact of this development on its financials will be negligible.
On December 10, 2015 15:15 (IST)
Scientists at Weizmann Institute have developed a recombinant enzyme currently undergoing animal studies for indications of brain stroke and glioblastoma.
On December 07, 2015 16:19 (IST)
Sun Pharma shares have underperformed the broader Nifty in the last three months as the company is struggling with issues at its Halol manufacturing facility, Ranbaxy integration as well as pricing pressure in the United States, the company's largest market.
On December 04, 2015 12:47 (IST)
Drug major Sun Pharmaceutical Industries on Friday said one of its subsidiaries has received approval of the US Food and Drug Administration (FDA) to manufacture and market generic version of Novartis' Gleevec, used in treatment of cancer, in America.
On December 04, 2015 16:08 (IST)
Sun Pharma is expected to commercially launch the product on February 1, 2016. "Under the terms of a settlement agreement with Novartis, the Sun Pharma subsidiary is permitted to launch its version of generic Gleevec in the United States on February 1, 2016," the company said.
On November 26, 2015 17:35 (IST)
Shares of Sun Pharma surged as much as 4.5 per cent to Rs 739 after its US-listed subsidiary Taro decided not to proceed with investment in wind energy projects.
On November 09, 2015 13:42 (IST)
The two drugmakers did not give any deadline for the issues to be resolved. Kotak analysts, however, estimate Sun Pharma's Halol site - a site it had owned before the Ranbaxy deal - could be cleared by the second half of 2016.
On November 09, 2015 12:38 (IST)
Consolidated net sales of the company declined to Rs 6,803.31 crore for the quarter under consideration as against Rs 7,979.31 crore for the same period a year ago.
On November 03, 2015 11:27 (IST)
Drug major Sun Pharmaceutical Industries on Tuesday said it has completed acquisition of US-based eye care firm InSite Vision.
On November 02, 2015 12:16 (IST)
Sun Pharma shares fell over 3 per cent on Monday after India's biggest pharma company said it expects revenues and net profit to be adversely hit in the short term due to supply constraints at its Halol facility in Gujarat and high expenses arising out of Ranbaxy integration as well as remedial actions.
On October 29, 2015 01:07 (IST)
Sun Pharmaceutical Industries on Wednesday said its arm Thea Acquisition Corp plans to exercise a 'top-up' option to purchase shares directly from eyecare firm InSite Vision to hold a 90 per cent stake in the US-based company to complete a merger, after failing to get the required number of shares through a tender offer.
On October 06, 2015 16:29 (IST)
Shares of Sun Pharma gained as much as 2 per cent on Tuesday after Ranbaxy Pharmaceuticals, a unit of India's biggest pharma company, settled a patent litigation with Actavis over the generic version of Absorica, which is used to treat acne.